Skip to main content

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 3, Number 3, 1 June 2002

Reviews

Furosemide Protective Effect Against Airway Obstruction
pp. 197-201(5)
Authors: Cavliere, F.; Masieri, S.

Favourites:
ADD

Multiple Drug Targets in the Management of Type 2 Diabetes
pp. 203-221(19)
Authors: Moneva, M.H.; Dagogo-Jack, S.

Favourites:
ADD

Novel Molecular Targets for Systemic Lupus Erythematosus
pp. 223-228(6)
Authors: Marino, M.; Rossi, M.; Ruvo, M.; Fassina, G.

Favourites:
ADD

Purine Signaling and Potential New Therapeutic Approach: Possible Outcomes of NTPDase Inhibition
pp. 229-245(17)
Authors: Gendron, F.P.; Krugh, O.B.B.; Kong, Q.; Weisman, G.A.; Beaudoin, A.R.

Favourites:
ADD
Favourites:
ADD

The Therapeutic Potential of Host-Defense Antimicrobial Peptides
pp. 259-267(9)
Authors: Sitaram, N.; Nagaraj, R.

Favourites:
ADD

Catalytic DNA: A Novel Tool for Gene Suppression
pp. 269-279(11)
Authors: Cairns, M.J.; Saravolac, E.G.; Sun, L.Q.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more